Child and adolescent health in the United States continues to lag behind that of other industrialized nations, with the US health care system falling short in tackling current threats (eg, childhood obesity and substance use epidemics) as well as future threats (eg, rising adult health disparities that may reflect adverse childhood influences). The emphasis on short-term financial returns partly explains this failure insofar as well-being outcomes for children are best measured over the long term. Attracting the attentions of payers and policy makers to increased and innovative funding for children’s health care has been difficult, as more costly adult needs often overshadow child-specific needs. The move toward value-based payment reform presents a critical opportunity for children’s health providers to make the case for the value of high-quality children’s health care, which warrants increased resources, and payment models that are specifically designed to improve children’s short- and long-term health and well-being outcomes.
|
|
Moving Beyond Joint Replacement: Expanding Payment Reforms To Better Incentivize Chronic Care For Degenerative Joint Disease
The article, published on the
Health Affairs
blog, is part of a broader effort by the Duke-Margolis Center for Health Policy, the Duke Department of Orthopaedic Surgery, and Dell Medical School at University of Texas at Austin to develop a new payment model that will better incentivize comprehensive care of this disease. The blog follows a January meeting that convened stakeholders from across the health care sector in January to discuss core components of the model, and continues to work with CMS, health insurers, and others to address challenges and begin developing a pilot program.
Read More.
|
|
“Duke is the perfect site to join us at this time,” said Linda Sarna, PhD, RN, FAAN, national board chair for the NCSP and dean of the UCLA School of Nursing. “They already have a strong community focus, and their nursing and medical schools are ranked among the top in the country.”
The NCSP was launched two years ago with four founding sites: UCLA, Yale, University of Pennsylvania, and University of Michigan. The program offers the opportunity for post-doctoral nurses (DNP and PhD) and physicians who have completed their clinical training to serve as leaders, researchers, and change agents in health care, community health, and public policy as full partners.
Read More.
|
|
Accountable Care for Serious Illness
On Thursday, March 22nd, Duke-Margolis, in collaboration with
Leavitt Partners
,
hosted a “Market Test” meeting in Washington, DC on how ACOs can improve the care of seriously ill patients. Over 40 participants from across the country represented perspectives from ACOs with serious illness programs; patient advocates; payers; and other clinical, consulting and academic experts in the serious illness space. The group discussed opportunities for the project to assist ACOs in taking immediate steps into serious illness care that maximize their current resources while also building toward a longer-term vision of the ideal state of serious illness care. Specifically, expert attendees focused on building a business case for ACOs to take on serious illness care, overcoming governance, financial, technological, and care model challenges, and in population targeting and performance tracking. This project is funded by the
Gordon and Betty Moore Foundation
.
|
|
Charlene Wong, MD, MSPH,
gave an invited talk at the NC Pediatric Society meeting on what the transformation to Medicaid Managed Care means for academic pediatricians.
|
|
Understanding the Development Challenges Associated with Emerging Non-Traditional Antibiotics
June 14, 2018 -
8:30 am to 5:00 pm
Location and Registration available soon!
Convened by the Duke-Robert J. Margolis, MD, Center for Health Policy at Duke University and supported by a cooperative agreement with FDA, this public event will focus on the range of non-traditional pharmaceutical approaches being developed to combat bacterial infections. Speakers will address the importance of development in this area, the full spectrum of technologies currently under development, and the outstanding scientific challenges in assessing efficacy of these products in pre-clinical and clinical settings. Discussion will help to prioritize challenge areas in which additional considerations and research will need to be developed moving forward.
|
|
About Duke-Margolis
The Duke-Margolis Center for Health Policy's mission is to improve health and the value of health care through practical, innovative, and evidence-based policy solutions.
This newsletter is published monthly by the Robert J. Margolis, MD, Center for Health Policy at Duke University.
|
|
|
|
|
|
|
